InnovAge Holding Corp. (INNV) Stock Price & Analysis
InnovAge Holding Corp. (INNV) closed at USD 8.98 on Thursday, October 15, 2026, down 1.10% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 9.08; the Oct 15, 2026 session ranged USD 8.92–9.23 on volume of 307,891 shares. Market capitalization is $1.23B, with a 52-week range of USD 3.94–12.64 (NMS). Source: Nexqual, retrieved October 16, 2026 at 05:20 UTC.
Also available as compact Markdown for AI agents: nexqual.com/INNV.md
Key facts (INNV)
- Analysts: Hold (mean 3.33 on a 1–5 scale) (3 analysts), mean target USD 12 (range 10–14).
- Total return with dividends: 1Y +63.3% vs S&P 500 +18.1%; 5Y +39.9% vs S&P 500 +85.1%.
- Next earnings: 2026-11-03, EPS estimate USD 0.09, revenue estimate $256M.
Analysts (INNV)
Consensus Hold (mean 3.33 on a 1–5 scale), 3 analysts; mean target USD 12 (low 10, high 14).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-09-09 | Keybanc | Target raised | Overweight | $13 → $14 |
| 2026-08-21 | Keybanc | Upgrade | Sector Weight → Overweight | $13 |
Total return (dividends reinvested) (INNV)
| 1Y (from 2025-10-16) | 5Y (from 2021-10-11) | |
|---|---|---|
| Total return | +63.3% | +39.9% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | +63.5% | +6.9% |
| Volatility (annualized) | 72.8% | 65.9% |
| Max drawdown | -33.2% (Mar 2026→Jun 2026) | -68.5% (Nov 2021→Apr 2025) |
Key Statistics (as of October 16, 2026 at 05:20 UTC)
| Price | USD 8.98 |
|---|---|
| Change | ▼ 1.10% (down) |
| Previous Close | USD 9.08 |
| Open | USD 9.18 |
| Day Range | USD 8.92 – 9.23 |
| 52-Week Range | USD 3.94 – 12.64 |
| Volume | 307,891 shares |
| Market Cap | $1.23B |
| Exchange | NMS |
Technical Analysis (INNV)
Nexqual's technical model rates INNV "STRONG SELL" based on 0 bullish and 5 bearish signals across 127 daily candles, as of October 16, 2026 at 05:20 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 34.5 (neutral) |
| vs SMA50 | Below (USD 10.19) |
| MACD | -0.37 (negative) |
Analyst Ratings (INNV)
Wall Street analysts rate INNV "Hold" based on 3 analysts, with a mean price target of USD 12 (range USD 10–14), per Nexqual as of October 16, 2026 at 05:20 UTC.
| Consensus Rating | Hold |
|---|---|
| Analyst Count | 3 |
| Mean Target | USD 12 |
| High Target | USD 14 |
| Low Target | USD 10 |
| Buy / Hold / Sell | 1 / 1 / 1 |
Earnings (INNV)
| Next Earnings Date | 2026-11-03 |
|---|---|
| EPS Estimate | USD 0.09 |
| Revenue Estimate | $255.85M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 0.1 vs est 0.08 ▲ beat |
| 2026-03-31 | USD 0.17 vs est 0.05 ▲ beat |
| 2025-12-31 | USD 0.1 vs est 0.04 ▲ beat |
| 2025-09-30 | USD 0.07 vs est 0.04 ▲ beat |
Source: Nexqual, October 16, 2026 at 05:20 UTC.
Financials & Fundamentals (INNV)
| Total Revenue | $989.71M |
|---|---|
| Revenue Growth (latest quarter, YoY) | +18.30% |
| Gross Margin | +68.46% |
| Operating Margin | +5.04% |
| Profit Margin | -0.26% |
| ROE | -0.26% |
| Debt / Equity | 0.32 |
| Current Ratio | 1.05 |
| Total Cash | $141.33M |
| Total Debt | $86.95M |
| Free Cash Flow (fiscal year ended Jun 2026, SEC 10-K) | $50.41M (5.1% of revenue) |
Source: Nexqual, October 16, 2026 at 05:20 UTC.
Financial Health Score (INNV)
Nexqual rates InnovAge Holding Corp.'s overall financial health "Solid" across five dimensions, as of October 16, 2026 at 05:20 UTC.
| Growth | Strong — Revenue +16% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 68%, operating 5% |
| Balance Sheet | Solid — $141M cash vs $87M debt, net cash position |
| Cash Flow | Solid — FCF $50M (FY ended Jun 2026, 10-K), 5% margin |
| Efficiency | Critical — ROE -0%, ROA 0.7% |
Ownership (INNV)
| Insider Ownership | +61.29% |
|---|---|
| Institutional Ownership | +14.97% |
| Shares Outstanding | 136.45M |
| Float | 32.42M |
| Short % of Float | +11.99% |
Source: Nexqual, October 16, 2026 at 05:20 UTC.
Leadership (INNV)
InnovAge Holding Corp. is led by Patrick Blair (age 54), Chief Executive Officer, per Nexqual as of October 16, 2026 at 05:20 UTC.
| Chief Executive Officer | Patrick Blair (age 54) |
|---|---|
| Independent Director | Edward Moore Kennedy Jr. (age 64) |
| Independent Director | Marilyn Barbour Tavenner M.H.A., R.N. (age 73) |
| President & COO | Jennifer Browne |
| Chief Financial Officer | Benjamin Crowninshield Adams (age 61) |
Major Backers & Investors (INNV)
Notable institutional backers of InnovAge Holding Corp. include T. Rowe Price, Federated Hermes, Inc., TR PRICE-Price (T.Rowe) U.S. Small-Cap Value Equity Trust, according to Nexqual as of October 16, 2026 at 05:20 UTC.
Active Investors
| Investor | Stake |
|---|---|
| T. Rowe Price | 6.95% |
| Federated Hermes, Inc. | 2.31% |
| TR PRICE-Price (T.Rowe) U.S. Small-Cap Value Equity Trust | 1.67% |
| Arrowstreet Capital, Limited Partnership | 0.49% |
| Algert Global, LLC | 0.46% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 1.51% |
| Vanguard Group | 1.36% |
| Geode Capital | 0.44% |
| State Street | 0.34% |
| Dimensional Fund Advisors | 0.32% |
Source: Nexqual, October 16, 2026 at 05:20 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| USPH | U.S. Physical Therapy, Inc. | USD 85.98 | ▲ 0.63% |
| NUTX | Nutex Health Inc. | USD 200.8 | ▼ 1.74% |
| HCSG | Healthcare Services Group, Inc. | USD 21.43 | ▲ 2.58% |
| PNTG | The Pennant Group, Inc. | USD 42.27 | ▲ 5.28% |
| AGL | agilon health, inc. | USD 88.45 | ▲ 2.97% |
| AMN | AMN Healthcare Services Inc | USD 40 | ▲ 9.47% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 16, 2026 at 05:20 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt